Moderna’s Intismeran mRNA cancer vaccine cuts melanoma recurrence and spread in late-stage trial Moderna and Merck report Intismeran reduced melanoma recurrence and metastasis in a late-stage trial; regulators are already …
The Calgary Tribune @2021 All rights reserved.